Wayne P Gulliver

Summary

Publications

  1. ncbi A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis
    Wayne P Gulliver
    Memorial University and Newlab Clinical Research Inc, St John s, Newfoundland, Canada
    Am J Ther 12:398-406. 2005
  2. ncbi A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis
    Gerald G Krueger
    University of Utah Health Sciences Center, Salt Lake City, USA
    J Am Acad Dermatol 47:821-33. 2002

Detail Information

Publications2

  1. ncbi A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis
    Wayne P Gulliver
    Memorial University and Newlab Clinical Research Inc, St John s, Newfoundland, Canada
    Am J Ther 12:398-406. 2005
    ..Taken together, these clinical studies conducted by several investigators in several countries indicate that Mahonia aquifolium is a safe and effective treatment of patients with mild to moderate psoriasis...
  2. ncbi A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis
    Gerald G Krueger
    University of Utah Health Sciences Center, Salt Lake City, USA
    J Am Acad Dermatol 47:821-33. 2002
    ..In previous phase II studies, alefacept significantly improved psoriasis and was well tolerated. The clinical response to alefacept was durable...